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IGF-II is abundant in the nascent mesoderm of the gastrulating mouse embryo. Its function at this developmental stage is
unknown. We investigated it by following the in vitro and in vivo differentiation of several androgenetic, biparental,
parthenogenetic, and androgenetic Igf2 2/2 murine ES cell lines; these cells differed in endogenous IGF-II levels because
gf2 is paternally expressed in the mouse embryo in most tissues. The expression of mesoderm markers and the subsequent
ormation of muscle structures were correlated with endogenous IGF-II level during teratoma formation and during in vitro
ifferentiation. In addition, the absence of Igf2 in androgenetic Igf2 2/2 ES cells led to a severe impairment of mesoderm
development, demonstrating the dependence of the preferential mesoderm development of androgenetic ES cells upon Igf2
ctivity, among the numerous known imprinted genes. The addition of exogenous IGF-II to in vitro differentiation culture
edium led to a specific increase in the expression of mesoderm markers. Thus, we propose a novel model in which the
inding of IGF-II to its principal signaling receptor, IGF1R, at the surface of mesoderm precursor cells increases the
ormation of mesoderm cells. © 2000 Academic Press
Key Words: IGF-II; cadherin; IGF1R; T-brachyury; imprinting; gastrulation; cardiogenesis; myogenesis; ES cells; mouse
embryo.1
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The insulin-like growth factor (IGF) family is extensively
involved in embryonic development (for review, see Efstra-
tiadis, 1998; van Kleffens et al., 1998). It includes two
oluble members (IGF-I and IGF-II), which bind with differ-
nt avidities to three known receptors [IGF1R, IGF2R, and
he insulin receptor (IR)]. IGF-II binds IGF2R, IGF1R, and
R, in decreasing order of avidity (Germain-Lee et al., 1992).
uring early development, Igf2 mRNA and protein are
roduced in the primitive endoderm at embryonic day 6.5
E6.5), then in the extraembryonic mesoderm cells as they
egin to appear (E7.0), and then, in the anterior-proximal
nd lateral embryonic mesoderm cells (E7.5). Later, Igf2 is
bundant in mesoderm derivatives such as the developing
eart (E8.0) and somites (E8.5) (Lee et al., 1990). Geneti-
ally, before E13.5, IGF-II signaling is transduced by the
GF1R only (Baker et al., 1993; Louvi et al., 1997). IGF2R is
nvolved during in vivo IGF-II degradation (Kiess et al.,
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o contribute to IGF-II signaling.
The various genes corresponding to these factors and
eceptors were disrupted in mice and growth alterations in
he resulting mutants were analyzed. In the absence of
GF-II, IGF1R, IGF-II and IGF1R, or IGF2R, dwarfism or
vergrowth was observed, with the mutants having birth
eight 60, 45, 30, or 140% that of the wild type, respec-
ively. Igf2 null mutants are viable and fertile (DeChiara et
l., 1990, 1991). Igf1r null mutants die immediately after
irth, from respiratory failure, and exhibit muscle hypopla-
ia, delayed ossification, and skin thinning (Liu et al., 1993).
onversely, inactivation of the Igf2r gene leads to perinatal
eath due to an increase in circulating IGF-II concentration
Lau et al., 1994); in particular, severe cardiac hyperplasia
as observed in these mice. These mutants can be com-
letely rescued from perinatal lethality in Igf2 or Igf1r null
enetic backgrounds (Ludwig et al., 1996). Other mouse
utants with increased circulating IGF-II concentration,
uch as H19 2/2; Igf2r 2/2 mice and mice presenting a
aternal duplication of chromosome 7, have abnormalities
imilar to those of Igf2r mutants and have additional
henotypes reminiscent of the Beckwith–Wiedemann syn-
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134 Morali et al.drome in humans (Eggenschwiler et al., 1997; McLaughlin
et al., 1997).
Several genes have parentally imprinted expression pat-
terns (for review, see Bartolomei and Tilghman, 1997). Igf2
and Igf2r are expressed according to a reciprocal parental
imprinting pattern, whereas Igf1r is not imprinted (Liu et
al., 1993). Only the paternally inherited Igf2 allele is ex-
pressed in most tissues (DeChiara et al., 1991), whereas
only the maternally inherited Igf2r allele is expressed in
wild-type embryos (Barlow et al., 1991). Embryonic stem
(ES) cells with entirely maternally (gynogenetic) or pater-
nally (androgenetic) inherited genomes can be classically
generated by pronucleus transfer (Mann et al., 1990;
McGrath and Solter, 1983, 1984). Parthenogenetic ES cells,
with entirely maternally inherited genomes, are generated
by ethanol induced activation of a one-cell egg (Allen et al.,
1994; Cuthbertson, 1983; Kaufman, 1982; Szabo and Mann,
1994). The differentiation potential of these mutant ES cells
has been tested in vivo and in vitro. Histological analysis of
the tumors derived from androgenetic ES cells showed a
much higher proportion of striated muscle than those from
biparental or parthenogenetic ES cells (Allen et al., 1994;
Mann et al., 1990). Similarly, embryoid bodies (EB) derived
from androgenetic ES cells synthesized myogenic regula-
tory factors earlier than those derived from biparental and
even more than those derived from parthenogenetic ES cells
(McKarney et al., 1997).
As the absence of IGFs or IGFRs in mutant mice or the
alteration of Igf2 and Igf2r expression in various parentally
imprinted ES cell lines strongly perturbs the formation of
mesoderm derivatives, we postulated a role for IGF-II in the
control of mesoderm formation in the mouse. In this work,
we investigated this hypothesis by following the formation
of mesoderm and mesoderm derivatives in wild-type, an-
drogenetic, parthenogenetic, and homozygous Igf2 2/2
androgenetic ES cells.
MATERIALS AND METHODS
Cell Culture and Transfection
Androgenetic MM9 (Ag1) and MM11 (Ag2) ES cells (Mann et al.,
1990), wild-type biparental D3M (Bip1) and R1 (Bip2) ES cells
(Doetschman et al., 1985; Nagy et al., 1993), parthenogenetic LG1
(Pg1) and LG5 (Pg2) ES cells (Szabo and Mann, 1994), and homozy-
gous Igf2 2/2 androgenetic MM7 (AgDIgf2-1) and MM17
(AgDIgf2-2) ES cells (McLaughlin et al., 1997) were used in this
study. LG1 and LG5 ES cells were kindly provided by Dr. J. Mann.
All murine ES cell lines were cultured at 37°C, in a 10% CO2
atmosphere, in DMEM high glucose (Gibco BRL), supplemented
with 15% heat-inactivated fetal calf serum (Boehringer Mann-
heim), 2 mM L-glutamine (Gibco BRL), 2000 units/ml leukemia
nhibiting factor (LIF) ESGRO (Gibco BRL), 71.5 mMb-mercaptoethanol (Sigma), 100 units/ml penicillin, and 100 mg/ml
streptomycin (Seromed).
Copyright © 2000 by Academic Press. All rightTeratoma Production and Histological Analysis
One million ES cells were injected subcutaneously into the
backs of 4- to 6-week-old male 129/Sv mice, as single-cell suspen-
sions in DMEM. Tumors approximately 1.5 cm in diameter were
split into two parts, to prepare DNA and for paraffin embedding.
Southern blot analysis were performed to check the genotypes of
the tumors. Tumors were fixed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) and embedded in paraffin by stan-
dard methods. Sections (5–7 mm) were stained with hematoxylin
and eosin.
In Vitro Differentiation of ES Cell Lines
The differentiation medium was identical to that described
above for ES cell culture medium except that fetal calf serum was
different (Techgen) and LIF ESGRO was omitted. For induction
experiments, 100 ng/ml (13.3 nM) recombinant human IGF-II
(Preprotech) was added to the differentiation medium. The general
procedure for in vitro differentiation was as previously described
Rohwedel et al., 1994). Calibrated developing EB were observed
aily by phase-contrast microscopy. Cell proliferation curves were
stablished daily during the first 7 days of in vitro differentiation by
rypsinizing 20 EB and counting the number of cells. Pseudocar-
iomyocyte development was evaluated by counting the number of
mbryoid bodies with periodically beating masses. Pseudo-muscle
ber and epithelial cyst development was evaluated in a similar
ay. Each experiment included at least 10 independent EB and at
east six independent experiments over a period of 1 year were
aken into account for every plot shown in Figs. 1 and 2.
Whole-Mount in Situ Hybridization on EB
A cDNA plasmid coding for T was used to prepare an antisense
riboprobe. In situ hybridization was performed on 4-day-old EB
according to Harland (1991) with minor modifications as described
in Mayor et al. (1995). Detection of the probe was performed using
he fluorescent antibody enhancer set for DIG detection (Boehr-
nger Mannheim). Control EB were incubated in the absence of
iboprobe. Finally, EB were sectioned optically from top to bottom
ith a laser scanning confocal microscope driven by Scanware
oftware (Leica). Control EB were routinely negative (data not
hown). The proportion of T-positive cells in a given EB was
stimated with Scion Image 1.62a software by calculating the mean
atio between the sum of the surfaces of labeled cells and that of the
urfaces of the EB on the corresponding optical sections.
Immunostaining
Attached EB were rinsed twice with PBS, fixed in 4% PFA (w/v)
for 10 min, rinsed with PBS for 10 min at room temperature,
permeabilized by incubation with 0.1% Triton X-100 for 5 min, and
rinsed with PBS. The immunostaining procedure for myosin light
chain-2V (MLC-2V) and myomesin 1 was as described previously
(Grove et al., 1984). Coverslips were mounted in Mowiol and
analyzed with a Leica fluorescence microscope. Control coverslips
were incubated in the absence of primary antibody. They were
routinely negative (data not shown). All collected images were
imported into Adobe PhotoShop 4.0 for further processing.
s of reproduction in any form reserved.
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135IGF-II Promotes Mesoderm FormationSemiquantitative RT-PCR Analysis of Marker Gene
Expression
Total RNA was extracted using the guanidium thiocyanate/acid
phenol method (Ausubel et al., 1988) and 1 mg of RNA was used as
a template for AMV reverse transcriptase (Stratagene). Semiquan-
titative PCR was performed as described elsewhere (Kandel et al.,
1991), using the primer pairs listed in Table 1. The amount of
mRNA for each marker was deduced from PCR product radioac-
tivity quantitation using PhosphorImager scans (Molecular Dy-
namics).
In Figs. 3, 4, and 6, mean measures and standard errors for a given
marker and a specific experiment were obtained in the different cell
lines from three to five independent experiments. These sets of
measures were normalized into arbitrary units for each marker,
with 10 being the highest value.
RESULTS
The Absence of Igf2 in Androgenetic Igf2 2/2 ES
Cells Impairs the Preferential Cardiomyocyte
Formation of Androgenetic Embryoid Bodies
The effect of Igf2 on the differentiation potential of
various ES cells was evaluated by analysis of the teratomas
TABLE 1
PCR Primers Used in This Study
Gene (usual
name)
Size of amplified
product (bp) 59 primer
nhbb (activin
bb)
426 59 GTC AAT TTG ACG TGG TTT CC
Afp (Afp) 410 59 GCT CAC ACC AAA GCG TCA AC
Col4a1
(collagen IV)
463 59 CAA GCA TAG TGG TCC GAG TC
Cdh1 (E-
cadherin)
111 59 CAT CGC CAC AGA TGA TGG TT
Cdh1 BGH pA 1027 59 CAT CGC CAC AGA TGA TGG TT
Fgf5 (Fgf5) 104 59 AAA CTC CAT GCA AGT GCC AA
Igf1R (Igf1R) 130 59 TGG CAC CTA CAG GTT CGA G
Igf2 (Igf2) 266 59 GGC CCC GGA GAG ACT CTG T
Igf2R (Igf2R) 235 59 CTG GAG GTG ATG AGT GTA G
CTG GC 39
Mesp1
(mesoderm
posterior 1)
204 59 ATG CCT TCC GAT GGG AAC A
Myf5 (Myf5) 308 59 CCA ACA GGC ATC TGT CCT TG
Myod1 (Myod) 425 59 CAC TAC AGT GGC GAC TCA GA
Myog
(myogenin)
513 59 AGC TCC CTC AAG CAG GAG G
Oct-4 (Pou5f1) 378 59 GAG TAT GAG GCT ACA GGG A
T (T-brachyury) 465 59 TCC AGG TGC TAT ATA TTG CC
Tubb (b-
tubulin)
318 59 TCA CTG TGC CTG AAC TTA CCderived from ES cells injected subcutaneously into isogenic
adult host mice and by analysis of the tissues produced in
Copyright © 2000 by Academic Press. All rightitro in the absence of LIF. In the absence of LIF, ES cells
ifferentiate spontaneously in vivo or in vitro, thereby
imicking postimplantation developmental events such as
seudogastrulation, -cardiogenesis, and -myogenesis (Bed-
ington and Robertson, 1989; Doetschman et al., 1985;
artin, 1975). In this article, we will now refer to pseudo-
ardiogenesis, -myogenesis, -cardiomyocytes, and -muscle
bers as cardiogenesis, myogenesis, cardiomyocytes, and
uscle fibers.
Two androgenetic (Ag1, Ag2), two biparental (Bip1, Bip2),
wo parthenogenetic (Pg1, Pg2), and two Igf2 2/2 androge-
etic (AgDIgf2-1, AgDIgf2-2) ES cell lines were used in these
tudies. No difference was observed between Ag1 and Ag2,
ip1 and Bip2, Pg1 and Pg2, or AgDIgf2-1 and AgDIgf2-2.
herefore, these cells will henceforth be referred to as Ag,
ip, Pg, and AgDIgf2, respectively.
The teratomas derived from these cells were analyzed
histologically and found to be mixed teratomas containing
various tissues. The proportions of muscle and neuroepi-
thelium were estimated by four histologists, who examined
the teratomas blindly. The androgenetic teratomas had a
high proportion of muscle and a low proportion of neuro-
epithelium; in comparison, the biparental teratomas had a
lower proportion of muscle and a higher proportion of
39 primer Reference
59 GCA AGA ATG TGC TGA TCA AC 39 Albano et al., 1993
59 CCT GTG AAC TCT GGT ATC AG 39 Keller et al., 1993
59 AGG CAG GTC AAG TTC TAG CG 39 Johansson and Wiles,
1995
59 AAC TGC ATG TTT CGA GGT TCT 39 X06115
59 GGT CAA GGA AGG CAC GGG GG 39 X06115 Larue et al.,
1996
59 CTT TTC AGT TCT GTG GAT CG 39 Johansson and Wiles,
1995
59 TGA TGG ACA CAC CTG CAT G 39 MGI: 1199209
59 GCC CAC GGG GTA TCT GGG GAA 39 Schuster-Gossler et al.,
1998
59 GAG TGA CGA GCC AAC ACA GAC
AGG TC 39
Szabo and Mann, 1995
59 GTG CGC ATA CGT AGC TTC TC 39 Saga et al., 1996
59 ACG TGC TCC TCA TCG TCT GA 39 Miller-Hance et al., 1993
59 TGC TGC TGC AGT CGA TCT CT 39 Miller-Hance et al., 1993
59 GGG CTC TCT GGA CTC CAT CT 39 Miller-Hance et al., 1993
59 AAT GAT GAG TGA CAG ACA GG 39 Larue et al., 1996
59 ACA AGA GGC TGT AGA ACA TG 39 Keller et al., 1993; Larue
et al., 1996
59 GGA ACA TAG CCG TAA ACT GC 39 Rohwedel et al., 199539
39
39
39
39
39
39
GC 39
CT
39
39
39
A 39
C 39
39
39neuroepithelium, and the parthenogenetic or the Igf2 2/2
androgenetic teratomas had an even lower proportion of
s of reproduction in any form reserved.
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(data not shown).
We investigated the role of Igf2 in the preferential differ-
ntiation of androgenetic teratomas into muscle, by allow-
FIG. 1. Cardiomyocyte development is modulated by the numbe
Ag (A); biparental, Bip (B); parthenogenetic, Pg (C); and homozygo
sing a microscope, on day 11 of in vitro differentiation. The a
videomicroscope observations (A9–D9). Scale bars represent 200 mm
periodically beating mass and the average frequency were calculatng ES cells expressing various levels of IGF-II to differen-
iate in vitro to produce preferentially cardiomyocytes and
o
s
Copyright © 2000 by Academic Press. All rightuscle fibers. Under our conditions, formation of the first
eriodically beating masses within the attached EB was
bserved 8 days after the beginning of in vitro differentia-
ion (Fig. 1). These beating masses were identified as cardi-
xpressed Igf2 alleles. Periodically beating masses in androgenetic,
f2 2/2 androgenetic, AgDIgf2 (D) attached EB were photographed
of beating masses within a given optical field was drawn from
average proportion of attached embryoid bodies with at least one
d plotted (E, F). Error bars indicate standard errors.r of e
us Ig
reamyocytes by immunodetection of the cardiac muscle-
pecific marker, MLC-2V, in the beating cells (data not
s of reproduction in any form reserved.
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137IGF-II Promotes Mesoderm Formationshown). The surface area of the beating regions increased
until day 11. On day 11, the surface of the beating masses
within EB was delimited by videomicroscopy (Figs. 1A–
1D9). Ag EB, consisting of cells with two expressed Igf2
lleles and two silent Igf2r alleles, had widely dispersed
eating surfaces (Figs. 1A and 1A9). Bip EB, consisting of
ells with one expressed Igf2 and one expressed Igf2r allele,
ad more restricted beating surfaces (Figs. 1B and 1B9),
hereas Pg EB, consisting of cells with two silent Igf2
lleles and two expressed Igf2r alleles, had even more
restricted beating areas (Figs. 1C and 1C9). AgDIgf2 EB,
consisting of cells with two null Igf2 and two silent Igf2r
alleles, had beating surfaces similar to those of Pg EB (Figs.
1D and 1D9). Hence, the surface area of the beating masses,
reflecting the number of cardiomyocytes, was directly cor-
related with the number of Igf2 alleles expressed. In par-
ticular, suppression of Igf2 expression from Ag ES cells
resulted in the abolition of the preferential differentiation
of Ag ES cells into cardiomyocytes. The proportion of EB
containing beating masses and the average beating fre-
quency were recorded daily in independent experiments
(Figs. 1E and 1F). On day 11 of in vitro differentiation, 111
of 126 Ag EB (88%) contained periodically beating masses.
The proportion of EB with beating masses was 72, 63, and
59% for Bip, Pg, and AgDIgf2 EB, respectively. The maxi-
mum mean beating frequency for Ag EB was 108 beats per
minute, whereas it was 63, 62, and 43 beats per minute for
Bip, Pg, and AgDIgf2 EB, respectively. Thus, among the
various imprinted genes differentially expressed in these
cell lines, differences in cardiomyocyte development can be
attributed to the amount of IGF-II produced in the various
cells.
The Absence of Igf2 in Androgenetic Igf2 2/2 ES
Cells Impairs the Preferential Muscle Fiber
Formation of Androgenetic Embryoid Bodies
Further development of mesoderm derivatives such as
muscle fibers in the differentiating EB was followed daily
for 1 month. Thereafter, Ag EB contained predominantly
long, thick fibers that self-contracted aperiodically (Fig. 2A).
Far fewer, much shorter and narrower fibers were observed
in Bip EB (Fig. 2B). In contrast, Pg and AgDIgf2 EB contained
predominantly epithelial cysts, indicating a probable bias
toward ectoderm and endoderm development (Figs. 2C and
2D). Very few, very short and very narrow fiber structures
were also observed in Pg and AgDIgf2 EB, whereas epithelial
cysts were never observed in Ag EB.
The proportion of EB containing muscle fibers was calcu-
lated from nine independent series of experiments (Fig. 2E).
On day 31 of in vitro differentiation, 69 of 82 Ag EB (84%)
contained muscle fibers, whereas the proportion was below
40% in Bip (36%), Pg (37%), and AgDIgf2 EB (27%). The
fibers observed by optical microscopy were identified as
muscle fibers using monoclonal antibodies directed against
myomesin 1 (Fig. 3A). The fibers observed in Ag EB were
thicker than those in Bip EB. Networks of thin fibers were
observed only in Bip EB, suggesting potential hindrance of
Copyright © 2000 by Academic Press. All rightusion into large fibers (Figs. 3A1–3A29). As expected, no
yomesin 1 was detected in AgDIgf2 EB (Figs. 3A3 and
3A39). In vitro myogenesis was further analyzed by assess-
ng the level of expression of the genes encoding the
yogenic bHLH transcription factors Myf5, Myod1 (Myod),
nd Myog (myogenin) by semiquantitative RT-PCR with
total RNA from the entire EB, using Tubb (Tubulin b) as an
internal reference (Figs. 3B–3D). These three myogenic
transcription factor genes were expressed at very low levels
in AgDIgf2 EB. Bip and Ag EB displayed similar Myf5
expression patterns. Myod1 expression occurred later in Bip
EB than in Ag EB. High levels of Myog expression were
detected only in Ag EB. It was genetically shown that
myogenin was involved in the fiber fusion (Arnold and
Braun, 1996). This may account for the thin fibers observed
in Bip EB.
The proportion of EB containing epithelial cysts was
calculated from nine independent series of experiments
(Fig. 2F). On day 31 of in vitro differentiation, 64 of 69 Pg EB
(93%) and 86% of the AgDIgf2 EB had formed epithelial
cysts. Such structures were rare in Bip EB (18%) and were
not observed in Ag EB.
Thus, the absence of Igf2 expression in Pg and in AgDIgf2
ES cells seems to have resulted in similar impairment in the
development of mesoderm derivatives such as cardiomyo-
cytes and muscle fibers. The expression of one or two Igf2
alleles is tightly correlated to the differentiation of ES cells
into mesoderm derivatives.
Endogenous IGF-II Induces Mesoderm Formation
To determine whether the bias toward the development
of mesoderm derivatives was due to a higher level of
recruitment and/or to a higher level of mesoderm cell
proliferation at the time of pseudogastrulation, the expres-
sion of specific markers for the three primary layers was
analyzed by semiquantitative RT-PCR in the EB over the
first 7 days of in vitro differentiation, using Tubb as an
nternal reference (Fig. 4). No significant differences in cell
roliferation were detected between the four ES cell lines
ver the first 7 days of differentiation (data not shown). T
brachyury) expression was monitored to evaluate the ki-
etics of early mesoderm formation. T expression began
arlier and lasted longer in Ag EB than in Bip EB, Pg EB, or
gDIgf2 EB (Fig. 4A). Three independent experiments were
arried out to quantify T expression on day 4 in the four
ypes of EB (Fig. 4C). T expression in Pg EB was half that in
ip EB and one-ninth that in Ag EB. T expression levels in
gDIgf2 EB were similar to those of Pg EB, reflecting the
nvolvement of Igf2 in the T expression observed in Ag EB.
imilar results were obtained with Mesp1 (mesoderm pos-
erior 1), a marker for mouse early posterior mesoderm
Saga et al., 1996), and Inhbb (inhibin bb), a marker for
mouse primitive ectoderm with potent mesoderm-inducing
activity in Xenopus (Albano et al., 1993; Steinbeisser et al.,
1993). Fgf5 expression was monitored to evaluate early
ectoderm development. Fgf5 expression in Pg EB was twice
that in Bip EB and 16 times higher than that in Ag EB.
s of reproduction in any form reserved.
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138 Morali et al.Unexpectedly, Fgf5 expression in AgDIgf2 EB was one-fifth
that of Pg EB, suggesting that pseudoectoderm formation
may be prevented by other paternally imprinted genes in
addition to Igf2. Similar levels of Col4a1 (procollagen, type
IV, a1) expression, indicating early pseudoendoderm devel-
FIG. 2. Muscle fiber development is modulated by the number of
elf-contracted aperiodically were observed in Ag EB (A). Far fe
B—arrowhead (B). In contrast, formation of epithelial cysts was ob
he insets (top left), shows the cellular organization at the surface
and 30 mm in the insets). The mean proportions of EB with at least
were calculated and plotted (E, F). Error bars indicate standard erroopment, were recorded for all types of EB. Similar results
were obtained for Afp, a marker for late endoderm develop-
e
m
Copyright © 2000 by Academic Press. All rightent (data not shown). Cdh1 (E-cadherin) expression was
monitored as a marker that is specifically down-regulated
in the nascent mesoderm (Vestweber and Kemler, 1984). It
was steady in all cell lines during the first 7 days of
differentiation. Finally, Oct-4 expression was evaluated to
essed Igf2 alleles. On day 31 of in vitro differentiation, fibers that
much shorter and much narrower fibers were observed in Bip
ed in Pg (C) and AgDIgf2 (D) attached EB. Higher magnification, in
e fibers (A, B) and of the cysts (C, D). Scale bars represent 200 mm
aperiodically self-contracting fiber and of EB with at least one cystexpr
wer,
serv
of thstimate the pluripotent primitive ectoderm cell develop-
ent (Nichols et al., 1998). Oct-4 expression was similar in
s of reproduction in any form reserved.
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139IGF-II Promotes Mesoderm FormationAg, Pg, and AgDIgf2 EB, suggesting that suppression of the
endogenous IGF-II production from Ag ES cells did not alter
the ability of AgDIgf2 ES cells to participate in some
embryonic tissue development. Moreover, Oct-4 expression
in Ag, Pg, and AgDIgf2 EB was half that of Bip EB, confirm-
ing that uniparental ES cells are partially affected in their
pluripotency. In order to determine whether the level of
mesoderm marker expression reflected the number of me-
FIG. 3. Molecular analysis of in vitro myogenesis. Myomesin 1, a
A19), Bip (A2, A29), and AgDIgf2 (A3, A39) EB on day 31 of i
phase-contrast microscopy images are shown in 1 to 3 and 19 to
encoding the three myogenic transcription factors Myf5, Myod1, a
internal reference. Relative levels of Myf5, Myod1, and Myog e
respectively.soderm cells induced at the time of pseudogastrulation in
the various types of EB, the proportion of T-expressing cells
Copyright © 2000 by Academic Press. All rightwas estimated by whole-mount in situ hybridization and
confocal microscopic analysis (Fig. 4D). The mean propor-
tion of labeled cells in Ag EB was 32%, whereas it was only
18.4% in Bip EB and 12% in Pg and in AgDIgf2 EB,
suggesting that the recruitment of mesoderm cells de-
pended upon Igf2 activity.
These results indicate that, cell growth rates being simi-
lar, the balance between mesoderm and ectoderm forma-
etal muscle fiber-specific marker, was immunodetected in Ag (A1,
ro differentiation. The corresponding immunofluorescence and
spectively. Scale bars represent 150 mm. Expression of the genes
yog was analyzed by semiquantitative RT-PCR, using Tubb as an
sion during in vitro differentiation are plotted in B, C, and D,skel
n vit
39, re
nd Mtion is strongly correlated with the number of Igf2 alleles
expressed. Moreover, the suppression of Igf2 expression
s of reproduction in any form reserved.
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tial mesoderm recruitment of these cells.
The Amount of Igf2 mRNA Is Higher in Ag Cells
at the Time of Pseudogastrulation
To assess more precisely the role of IGF-II at the time of
mesoderm formation, we monitored the expression of Igf2
and the genes for its two main receptors, Igf2r and Igf1r, in
Ag, Bip, Pg, and AgDIgf2 ES cells. Semiquantitative RT-PCR
analysis was performed on days 1, 4, 7, and 11 of in vitro
differentiation of these cells, using Tubb as an internal
reference (Fig. 5). As expected, no Igf2 expression was
FIG. 4. Molecular analysis of in vitro gastrulation. Expression of
semiquantitative RT-PCR during the first 7 days of in vitro differ
reference (A, B). Gene expression on day 4 was quantified for T, Mes
a marker of early ectoderm development; for Col4a1, a marker of
down-regulated in the nascent mesoderm; and for Oct4, a marker f
cells in Ag, Bip, Pg, and AgDIgf2 day 4 EB was calculated after whol
obtained by confocal microscopic analysis for Ag (top) and AgDIgf2
rrors.detected in AgDIgf2 cells. The amount of Igf2 RNA was
consistently low during the in vitro differentiation of Pg
t
t
Copyright © 2000 by Academic Press. All rightcells. On days 7 and 11, Igf2 was clearly expressed in Ag and
Bip cells. The amount of Igf2 RNA was significantly higher
in Ag than in Bip cells on days 4, 7, and 11, with estimated
ratios of 5, 1.6, and 1.8, respectively. The amount of Igf2r
mRNA was consistently low during the in vitro differentia-
tion of Ag, Bip, and AgDIgf2 cells. Igf2r expression was
clearly detectable in Pg cells from day 4 onward. The
amount of Igf1r mRNA was constant and similar in the
various cells during the first 11 days of in vitro differentia-
tion.
These results show that Igf2 and Igf2r were correctly
mprinted in the cells used for this study. In addition, the
emporal expression patterns of Igf2 and of the genes for its
molecular marker of early mesoderm formation, was analyzed by
tion of Ag, Bip, Pg, and AgDIgf2 cells, using Tubb as an internal
nd Inhbb, three markers of early mesoderm development; for Fgf5,
endoderm development; for Cdh1, a marker which is specifically
e pluripotent primitive ectoderm (C). The proportion of mesoderm
unt in situ hybridization for T (D). Insets show examples of images
tom) EB. Scale bar represents 50 mm. Error bars indicate standardT, a
entia
p1, a
early
or th
e-mowo main receptors, Igf2r and Igf1r, indicated that, at the
ime of pseudogastrulation, the amount of available endog-
s of reproduction in any form reserved.
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141IGF-II Promotes Mesoderm Formationenous IGF-II was significantly higher in Ag cells than in Bip
cells, whereas it was negligible in Pg and in AgDIgf2 cells.
Exogenous IGF-II Increases T Expression
To determine whether IGF-II was indeed responsible for
the higher level of mesoderm formation, in vitro differen-
iation experiments were carried out in the presence of
uman recombinant IGF-II. A dose-effect curve was estab-
ished with each cell line by analyzing the induction of T
xpression by RT-PCR on day 4 for IGF-II concentrations
anging from 0 to 1000 ng/ml (Fig. 6A). An optimal T
xpression was observed in Ag EB with IGF-II concentra-
ions ranging from 10 to 1000 ng/ml. For Bip EB, T expres-
ion increased steadily until an IGF-II concentration of 1000
g/ml. In Pg EB, no increase of T expression was observed
FIG. 5. Expression patterns of Igf2, Igf2r, and Igf1r during in vitro
differentiation. The expression of Igf2, Igf2r, and Igf1r was analyzed
on days 1, 4, 7, and 11 of in vitro differentiation by semiquantita-
tive RT-PCR, using Tubb as an internal reference.
FIG. 6. Exogenous IGF-II induces T expression and reduces Fgf5
allowed to occur in the presence of human recombinant IGF-II
differentiation, the relative levels of T expression in Ag, Bip, Pg, an
as an internal reference (A). At an IGF-II concentration of 100 ng/ml, th
AgDIgf2 were determined by semiquantitative RT-PCR, using Tubb as
Copyright © 2000 by Academic Press. All rightith the IGF-II concentrations used. Finally, in AgDIgf2 EB,
expression was optimal at concentrations ranging from 10
o 1000 ng/ml. Therefore, an IGF-II concentration of 100
g/ml was chosen for induction experiments. The expres-
ion of the primary layer-specific markers described above
as analyzed by semiquantitative RT-PCR over the first 7
ays of in vitro differentiation. Independent experiments
ere used to quantify T and Fgf5 expression on day 4 in the
our types of EB (Fig. 6). In Ag EB, the expression of T and
gf5 was not affected by the addition of IGF-II to the in vitro
ifferentiation medium. In Bip, Pg, and AgDIgf2 EB, T
xpression levels in IGF-II-treated EB were twice those in
ntreated EB. Fgf5 expression in Bip, Pg, and AgDIgf2 EB
as decreased by a factor of 3 in the presence of recombi-
ant IGF-II. Therefore, the addition of IGF-II to the differ-
ntiation medium specifically increased the expression of
esoderm markers and decreased the expression of ecto-
erm markers in ES cells expressing no or one Igf2 allele. ES
ells expressing two Igf2 alleles were not sensitive to the
ose of IGF-II used in this experiment, suggesting the
aturation of the IGF-II signaling machinery by the endog-
nous IGF-II secreted by these cells.
DISCUSSION
Igf2 and Igf2r Imprinted Expression in ES Cells
during in Vitro Differentiation
In the mouse embryo, the expression of Igf2 and Igf2r is
parentally imprinted. Igf2 is expressed only if inherited
ression during in vitro gastrulation. In vitro differentiation was
entrations ranging from 0 to 1000 ng/ml. On day 4 of in vitro
DIgf2 were determined by semiquantitative RT-PCR, using Tubbexp
conc
d Age relative levels of T (B) and Fgf5 (C) expression in Ag, Bip, Pg, and
an internal reference. Errors bars indicate standard errors.
s of reproduction in any form reserved.
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142 Morali et al.paternally (DeChiara et al., 1991), whereas Igf2r is ex-
pressed only if inherited maternally (Barlow et al., 1991). In
biparental embryos, Igf2 expression becomes monoallelic
after implantation: its expression is biallelic in the blasto-
cyst and purely paternal at E6.5. In Bip embryos, Igf2r
expression is biallelic from the four-cell stage and remains
so throughout embryonic development, although it is
strongly maternally biased. In uniparental—androgenetic
(Ag), gynogenetic, or parthenogenetic (Pg)—embryos, the
inactivation of imprinted genes is similar to that in bipa-
rental embryos (Latham et al., 1994; Szabo and Mann,
1995). In mammals, postimplantation stages are difficult to
study in vivo for two main reasons: developmental pro-
cesses occur in utero and the embryos are fragile. These
limitations can be partly circumvented using ES cell lines.
ES cells are classically derived from mouse blastocyst inner
cell mass at E3.5. These cells are pluripotent, may be
obtained from any desired mouse wild-type or mutant
strains, and can be genetically manipulated. In the absence
of LIF, these cells differentiate spontaneously in vivo or in
vitro, thereby mimicking postimplantation developmental
events such as pseudogastrulation, -cardiogenesis, and
-myogenesis (Beddington and Robertson, 1989;
Doetschman et al., 1985; Martin, 1975). ES cells containing
a full maternal or paternal genome can be derived from Pg
or Ag embryos, respectively. Expression patterns of known
imprinted genes were determined by Northern blot analysis
in undifferentiated and differentiated ES cells. On day 9 of
in vitro differentiation, Igf2 and Igf2r are appropriately
expressed in Pg, Bip, and Ag ES cells (Allen et al., 1994;
Szabo and Mann, 1994).
Here, we analyzed Igf2 and Igf2r expression during the in
vitro differentiation of Bip, Ag, Pg, and AgDIgf2 ES cells by
semiquantitative RT-PCR. On day 4 of in vitro differentia-
tion, Igf2 and Igf2r were already appropriately imprinted.
The specific in vitro differentiation procedure and the
sensitivity of the RT-PCR technique may account for the
5-day lag observed between our results and those of previ-
ous studies (Allen et al., 1994; Szabo and Mann, 1994). As
expected, the correctly imprinted expression patterns were
also observed later. Thus, we used ES cells producing large
(Ag), intermediate (Bip), negligible (Pg), and undetectable
(AgDIgf2) amounts of IGF-II from day 4 of in vitro differen-
tiation to investigate the role of IGF-II in the differentiation
of cells into mesodermal tissues.
Genetic Evidence for the Specific Involvement of
Igf2 in Heart and Muscle Development
ES cells have been used to study cardiogenesis in vitro. At
the molecular level, this in vitro system showed temporal
fidelity in the progression of in vivo cardiogenesis, even
though positional cues and physiological stimuli were ab-
sent (Miller-Hance et al., 1993).
In this study, we showed that in vitro cardiogenesis at the
physiological, cellular, and molecular levels was dependent
upon Igf2 activity specifically. The absence of Igf2 was
irectly involved in the impaired formation of cardiomyo-
p
p
Copyright © 2000 by Academic Press. All rightytes by comparing the development of Ag and AgDIgf2 EB.
ur results show that the proportion of EB containing
eating masses, the surface area of the beating mass within
n EB, and the maximum mean beating frequency were
irectly correlated with the amount of endogenous IGF-II
roduced. These results suggest that IGF-II increases the
ifferentiation of ES cells into cardiomyocytes. Larger doses
f IGF-II increased the surface area of the beating mass,
hich was directly correlated with the number of cardio-
yocytes present in the beating mass. The proportion of
ardiomyocytes within a beating mass, as indicated by the
umber of MLC-2V-positive cells (data not shown), may
ccount for the differences in current conduction and there-
ore in maximum mean beating frequency (Thomas et al.,
998). Thus, these results indicate that Igf2 increases car-
iomyocyte development in vitro. This conclusion is con-
istent with previous data obtained in vivo (Eggenschwiler
t al., 1997; Lau et al., 1994; Ludwig et al., 1996). IGF-II
verproduction in vivo, as a result of disruption of Igf2r or
f Igf2r and H19 genes, resulted in perinatal death with
utant embryos exhibiting, in particular, thickening of the
entricle wall with no cardiomyocyte hypertrophy, suggest-
ng hyperplasia of heart cell types.
ES cells have also been used to study myogenesis in vitro
McKarney et al., 1997; Rohwedel et al., 1994). Plurinucle-
ted fibers that self-contract aperiodically can be formed in
itro, with the temporal expression pattern of the myogenic
ranscription factors conserved, even though positional
ues and physiological stimuli are absent. Therefore, ES
ells have the advantage of recapitulating myogenesis more
ompletely than the various myogenic cell lines derived
rom adult muscles, which have only myoblastic properties
Richler and Yaffe, 1970; Yaffe, 1968; Yaffe and Saxel, 1977).
In this study, in vitro myogenesis at the physiological,
ellular, and molecular levels was dependent upon Igf2
ctivity specifically. The absence of Igf2 was directly in-
olved in the impaired formation of fibers by comparing the
evelopment of Ag and AgDIgf2 EB. Our results show that
he proportion of EB containing fibers, the thickness of the
bers, and the levels of endogenous Myod1 and Myog
xpression are directly correlated with the amount of en-
ogenous IGF-II produced. These results suggest that larger
mounts of IGF-II increase differentiation from ES cells into
bers, accelerate the onset of Myod1 expression, and in-
rease the thickness of fibers by increasing the amount of
yogenin produced (Andres and Walsh, 1996; Arnold and
raun, 1996; Venuti et al., 1995). These results indicate that
utocrine IGF-II secretion by differentiating ES cells in-
reases fiber development in vitro. This conclusion is
onsistent with previous data obtained in vitro. First,
yod1 expression is stimulated by autocrine IGF-II secre-
ion in C2 myoblasts (Florini et al., 1991b; Montarras et al.,
996). Second, Myog expression is strongly induced by
utocrine IGF-II secretion in C2 myoblasts (Ewton et al.,
994; Florini et al., 1991a,b). In vivo, no specific muscle
henotype is clearly documented in mouse mutants over-
roducing IGF-II as a result of disruption of the Igf2r or Igf2r
s of reproduction in any form reserved.
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bserved.
IGF-II Modulates Mesoderm Formation
In vivo, cardiomyocytes and skeletal muscles are derived
from the lateral and dorsal mesoderm, respectively. There-
fore, an increase in cardiogenesis and myogenesis suggests
that mesoderm formation in vitro, at the time of pseudo-
gastrulation, is also increased. In vivo, gastrulation is a
fundamental developmental process by which the defini-
tive body plan is acquired by the embryo. This developmen-
tal step involves the formation of a third primary layer,
mesoderm, which arises between the ectoderm and the
endoderm.
A wide variety of proteins have been implicated in the
formation of the three primary layers in vertebrates. These
include growth factors and their receptors, cell adhesion
and extracellular matrix molecules, and transcription fac-
tors. Studies in various vertebrate models have provided
evidence for a mesoderm-inducing roles of members of the
fibroblast growth factor (FGF) family, of the Wnt family,
and of the transforming growth factor b superfamily, such
as activins and bone morphogenetic proteins (for review,
see Heasman, 1997; Tam and Behringer, 1997). Here, we
provide the first piece of evidence for the involvement of a
member of the IGF family in mesoderm formation.
In this study, the formation of the three primary cell
lineages was influenced by Igf2 activity. With AgDIgf2 ES
cells and by adding recombinant IGF-II, we demonstrated
that higher IGF-II concentrations correlate with pseudogas-
trulation biased toward pseudomesoderm formation. The
various amounts of IGF-II produced by the differentiating
ES cells did not seem to affect their proliferation rate over
the first 7 days of in vitro differentiation. Moreover, by
following the expression of the primitive ectoderm-specific
marker Inhbb, the early mesoderm-specific marker
T-Brachyury, the primitive endoderm-specific marker col-
lagen a IV, the visceral endoderm-specific marker Afp, and
the early embryonic ectoderm-specific marker Fgf5, we
found that genes with an exclusive paternal allelic expres-
sion, and Igf2 in particular, biased the in vitro differentia-
tion of ES cells toward mesoderm formation. These results
do not appear to be consistent with the data presented in a
previous study (Szabo and Mann, 1994). In that study, total
RNA was analyzed by Northern blotting rather than by
semiquantitative RT-PCR, using Mhox, Sparc, and Afp
probes. During normal development, Mhox, Sparc, and Afp
expression indicates differentiation toward diverse meso-
derm and parietal and visceral endoderm lineages, respec-
tively. Therefore, these markers are less general primary
cell lineage indicators than the ones we used.
Given that no obvious difference was observed in terms
of cell proliferation, the results of semiquantitative RT-
PCR and of whole-mount in situ hybridization for T in day
4 EB clearly indicate that the recruitment of pseudomeso-
derm cells was dependent upon Igf2 activity. Several
mechanisms may account for the effect of IGF-II on the
Copyright © 2000 by Academic Press. All rightrecruitment of mesoderm cells in day 4 EB. For instance,
IGF-II may cause (i) a biased determination of primitive-
ectoderm cells toward mesoderm or (ii) selective prolifera-
tion of the already determined mesoderm cells. The mecha-
nism cannot be deduced at this point. However, IGF-II is
known to act both as a mitogen and as a differentiation
factor by triggering different signaling pathways at the same
time (Stewart and Rotwein, 1996; Coolican et al., 1997).
Therefore, IGF-II may well cause both the determination
and the proliferation of mesoderm cells.
In vivo, a series of gene disruption experiments of mem-
bers of the IGF family was conducted to determine the
importance of these molecules in mouse growth (for review,
see Efstratiadis, 1998). Mouse mutants were analyzed from
E10 onward. This may explain why no mesoderm pheno-
type was reported. Nevertheless, Igf1 null mutants dis-
played clear phenotypes in mesoderm derivatives, including
extensive muscle hypoplasia (Powell-Braxton et al., 1993).
Igf2 null mutants did not display such a phenotype. This
was probably due to functional compensation by IGF-I
during development, as shown by the more severe muscle
hypoplasia observed in Igf1 2/2; Igf2 2/2 mutants than in
gf1 2/2 mutants (DeChiara et al., 1990; Liu et al., 1993).
The results presented here suggest that the analysis of
astrulating Igf1, Igf2, or Igf1r mutants should reveal some
hanges in mesoderm formation. As for Igf2, the disruption
f genes encoding known in vitro mesoderm inducers such
s activin A and FGF2 has not led to mesoderm-deficiency
henotypes (Dono et al., 1998; Matzuk et al., 1995; Ortega
t al., 1998). We think it is possible that the combination of
ene disruptions for inhibin-bA or for Fgf2 and for Igf2 may
lead to detectable mesoderm phenotypes.
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